Prader-willi syndrome stories

Aug 12, 2026

Prader-Willi syndrome experts raise safety concerns over Neurocrine's Vykat XR

Medical experts specializing in Prader-Willi syndrome flagged serious adverse events in patients taking Neurocrine Biosciences' drug Vykat XR, raising safety concerns about the treatment for the rare genetic disorder.

Aug 12, 20262 sources

Apr 6, 2026

Neurocrine Biosciences Acquires Soleno Therapeutics for $2.9 Billion

Neurocrine Biosciences is acquiring Soleno Therapeutics in a $2.9 billion deal to gain an approved medicine for a rare disease that causes insatiable hunger.

Apr 6, 20261 source